These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serotonergic function and self-injurious behavior in personality disorder patients. New AS; Trestman RL; Mitropoulou V; Benishay DS; Coccaro E; Silverman J; Siever LJ Psychiatry Res; 1997 Mar; 69(1):17-26. PubMed ID: 9080541 [TBL] [Abstract][Full Text] [Related]
3. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Coccaro EF; Lee R; Kavoussi RJ Neuropsychopharmacology; 2010 Jan; 35(2):435-44. PubMed ID: 19776731 [TBL] [Abstract][Full Text] [Related]
4. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Cleare AJ; Bond AJ Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176 [TBL] [Abstract][Full Text] [Related]
5. The anxiogenic drug FG7142 increases self-injurious behavior in male rhesus monkeys (Macaca mulatta). Major CA; Kelly BJ; Novak MA; Davenport MD; Stonemetz KM; Meyer JS Life Sci; 2009 Nov; 85(21-22):753-8. PubMed ID: 19837095 [TBL] [Abstract][Full Text] [Related]
6. Altered hypothalamic-pituitary-adrenocortical function in rhesus monkeys (Macaca mulatta) with self-injurious behavior. Tiefenbacher S; Novak MA; Marinus LM; Chase WK; Miller JA; Meyer JS Psychoneuroendocrinology; 2004 May; 29(4):501-15. PubMed ID: 14749095 [TBL] [Abstract][Full Text] [Related]
7. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Soloff PH; Lynch KG; Moss HB Alcohol Clin Exp Res; 2000 Nov; 24(11):1609-19. PubMed ID: 11104107 [TBL] [Abstract][Full Text] [Related]
8. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study. Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278 [TBL] [Abstract][Full Text] [Related]
9. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group. Prochazka H; Sjögren M; Agren H J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832 [TBL] [Abstract][Full Text] [Related]
10. Thermal response to serotonergic challenge and aggression in attention deficit hyperactivity disorder children. Donovan AM; Halperin JM; Newcorn JH; Sharma V J Child Adolesc Psychopharmacol; 1999; 9(2):85-91. PubMed ID: 10461818 [TBL] [Abstract][Full Text] [Related]
11. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects. Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375 [TBL] [Abstract][Full Text] [Related]
12. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats. Baumann MH; Ayestas MA; Rothman RB J Neurosci; 1998 Nov; 18(21):9069-77. PubMed ID: 9787010 [TBL] [Abstract][Full Text] [Related]
13. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977 [TBL] [Abstract][Full Text] [Related]
14. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects. Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of diazepam treatment for the management of acute wounding episodes in captive rhesus macaques. Tiefenbacher S; Fahey MA; Rowlett JK; Meyer JS; Pouliot AL; Jones BM; Novak MA Comp Med; 2005 Aug; 55(4):387-92. PubMed ID: 16158915 [TBL] [Abstract][Full Text] [Related]
16. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135 [TBL] [Abstract][Full Text] [Related]
17. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Soloff PH; Kelly TM; Strotmeyer SJ; Malone KM; Mann JJ Psychiatry Res; 2003 Jul; 119(1-2):11-24. PubMed ID: 12860356 [TBL] [Abstract][Full Text] [Related]
18. Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: a continuous infusion PET study in conscious monkeys. Udo de Haes JI; Harada N; Elsinga PH; Maguire RP; Tsukada H Synapse; 2006 Jan; 59(1):18-26. PubMed ID: 16237679 [TBL] [Abstract][Full Text] [Related]
19. In vivo correlates of central serotonin function after high-dose fenfluramine administration. Baumann MH; Ayestas MA; Rothman RB Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672 [TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects. Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]